Institutional Ownership
Sinovac Biotech Ltd
CUSIP P8696W104SHSSVAQ1 2026
Institutional Holders
29
13F filers
Shares Held
10.49M
Aggregate institutional
Institutional Value
$222.87M
Q1 2026
Net New Holders
+1
4 new · 3 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions4
Increased4
Decreased2
Sold out3
Institutional Holders
29 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Orbimed Advisors LLC | 2.72M | $184.47M | 0 | Held |
| 2 | Vivo Capital, LLC | 5.90M | $38.19M | 0 | Held |
| 3 | Susquehanna International Group, LLP | 16.4K | $106.3K | 0 | Held |
| 4 | Morgan Stanley | 9.1K | $59.2K | 0 | Held |
| 5 | Wells Fargo & Company/Mn | 4.8K | $31.1K | −12.1K | Reduced |
| 6 | Ubs Group AG | 2.2K | $14.4K | −7.0K | Reduced |
| 7 | Neumann Advisory Hong Kong Ltd | 315.6K | $2.0K | 0 | Held |
| 8 | Horizon Investments, LLC | 104 | $673 | +52 | Added |
| 9 | Harbour Investments, Inc. | 83 | $542 | +83 | New |
| 10 | Jones Financial Companies Lllp | 338 | $0 | 0 | Held |
19 more institutional holders on Premium
See every fund holding Sinovac Biotech Ltd, with full quarter-over-quarter share changes.
Unlock all holders